EFTA00822666.pdf

DataSet-9 2 pages 241 words document
V15
👁 1 💬 0
📄 Extracted Text (241 words)
From: "Ens, Amanda" To: "jeevacation®gmail.com" <jeevacation®gmail.com> Subject: Invitation to the BofAML 2016 Life Sciences & Medical Technology Innovation Forum, 18- Aug (NYC) Date: Wed, 03 Aug 2016 20:13:26 +0000 Attachments: Agenda_Draft_V5.pdf Inline-Images: image002.png Jeffrey, I'm looking forward to working with you and building a dialogue. This event is a unique opportunity to see the cutting edge of what medical technology and life sciences has on offer (synthetic biology, genomics, robotics, etc). Please let me know if you would like to attend. We expect to have —70 institutional buyside clients at the event. The Bank of America Merrill Lynch 2016 Life Sciences & Medical Technology Innovation Forum will take place Thursday, August 18th at One Bryant Park in New York, NY. Current agenda 10:30 a.m. — 10:55 a.m. Registration 10:55 a.m. — 11:00 a.m. Welcome introduction 11:00 a.m. - 4:00 p.m. Topical Presentations will include: Payment model innovation Synthetic Robotics Population Biology Synthetic Biology Genomics & Big Data 3D Printing "Agenda and invitation attached Regards, Amanda Amanda Ens Director Bank of America Merrill Lynch Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park, 5th Floor, New York, NY 10036 Phone: Mobile The power of global connections"' Rcid:image001.png@0lD1B4D 2.34B2F410 EFTA00822666 This message, and any attachments, is for the intended recipient(s) only, may contain information that is privileged, confidential and/or proprietary and subject to important terms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the intended recipient, please delete this message. EFTA00822667
ℹ️ Document Details
SHA-256
704b64548b632353c2c23a4325db421be5858b3f36e42eeba6ded578b8060393
Bates Number
EFTA00822666
Dataset
DataSet-9
Type
document
Pages
2

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!